Adenoviral vectors have emerged as a pivotal platform in gene therapy owing to their efficient gene delivery and high transgene expression. Their application spans from vaccine development to ...
Amid a reckoning for the gene therapy field, Vertex Pharmaceuticals has joined a growing list of companies paring back their research efforts around the adeno-associated virus (AAV) vectors used to ...
Co announces that a patent has been awarded titled "Diminishing Viral Gene Expression by Promoter Replacement" by the U.S. Patent and Trademark Office focusing on adenoviral vector development, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results